Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01284283 · ClinicalTrials.gov registry record · NA
2-Year Post-Approval Study to Investigate the Scandinavian Total Ankle Replacement System (STAR) Ankle Under Actual Conditions of Use
A NA study of Rheumatoid Arthritis and Osteoarthritis, sponsored by Encore Medical, L.P..
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
- 9
- Study locations
NCT01284283: Completed NA study of Rheumatoid Arthritis and Osteoarthritis, sponsored by Encore Medical, L.P..
NCT01284283 is a NA study of Rheumatoid Arthritis and Osteoarthritis that has completed, run by Encore Medical, L.P.. The registered enrollment target is 102 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (98% lower). The trial reports 9 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01284283, a NA study of Rheumatoid Arthritis and Osteoarthritis, has completed, sponsored by Encore Medical, L.P..
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
- 9
- Study locations
Study Summary
This post-approval study is being conducted to examine the performance of the STAR Ankle under actual conditions of use.
Primary Outcome
The primary objective of this study is to examine the performance of the STAR™ Ankle under actual conditions of use, employing the approved instructions for use, labeling, and instrumentation. The principal endpoint consists of evaluating the safety and effectiveness of the STAR™ Ankle. Overall patient success is defined as: 1. ≥ 40 point improvement in total Buechel-Pappas Scale score 2. No device failures 3. Radiographic success (no clinically significant radiographic evidence of loosening, t
Conditions Studied
Interventions
- DEVICE Scandinavian Total Ankle Replacement System (STAR Ankle)
Study Locations (9)
California
- Cedars Sinai Medical Center - Los Angeles
- Palo Alto Medical Research Foundation (Sutter Health) - Palo Alto
- Kaiser Permanente - San Francisco
Arizona
- The CORE Institute - Phoenix
Michigan
- William Beaumont Hospital - Royal Oak
Nevada
- Reno Orthopaedic Center - Reno
New York
- Kenneth Mroczek, MD-NYU - New York
Pennsylvania
- University of Pennsylvania Health Systems-PA Foot and Ankle Surgeons - Philadelphia
Texas
- Center for Foot and Ankle Restoration - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2009-11 |
| Est. Completion | 2021-03 |
| Phase | NA |
What the finished NCT01284283 record still lists
NCT01284283 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (98% lower).
The record links to 4 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Scandinavian Total Ankle Replacement System (STAR Ankle) is the first listed.
NCT01284283 lists 9 locations in 7 states (California, Arizona, Michigan).
Frequently Asked Questions
What is clinical trial NCT01284283 about?
NCT01284283 is a clinical study titled "2-Year Post-Approval Study to Investigate the Scandinavian Total Ankle Replacement System (STAR) Ankle Under Actual Conditions of Use". This post-approval study is being conducted to examine the performance of the STAR Ankle under actual conditions of use.
What is the current status of trial NCT01284283?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2009-11. Estimated completion is 2021-03.
What conditions does trial NCT01284283 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Post Traumatic Arthritis, Primary Arthrosis.
What interventions are being tested in trial NCT01284283?
The interventions under investigation include: Scandinavian Total Ankle Replacement System (STAR Ankle) (DEVICE).
Who is sponsoring clinical trial NCT01284283?
This trial is sponsored by Encore Medical, L.P., which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01284283 being conducted?
This trial has 9 study locations across Arizona, California, Michigan, Nevada, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01284283's enrollment target sits among peer trials
102 115th of 197 higher than 83 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis
RECRUITING · NA
-
Improving Hypertension Control in Rheumatoid Arthritis
RECRUITING · NA
-
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia